Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Drug-Related Side Effects and Adverse Reactions 12Lung Neoplasms 10Head and Neck Neoplasms 10Ovarian Neoplasms 8Radiation Injuries 7Carcinoma, Ovarian Epithelial 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 5Lymphoma, Non-Hodgkin 5Lymphoma 5Leukemia 5Hodgkin Disease 5Breast Neoplasms 5Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Burkitt Lymphoma 4Prostatic Neoplasms 3Neurotoxicity Syndromes 3Neuroectodermal Tumors, Primitive, Peripheral 3Xerostomia 2Waldenstrom Macroglobulinemia 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2

Interventions

Irinotecan 6Cyclophosphamide 3temsirolimus 2Sirolimus 2Early Intervention, Educational 2reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Tirapazamine 1Thalidomide 1Temozolomide 1Pemetrexed 1Oxaliplatin 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Filgrastim 1Enzyme-Linked Immunosorbent Assay 1Counseling 1Cisplatin 1Carboplatin 1Bortezomib 1Bevacizumab 1Amifostine 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Unspecified Childhood Solid Tumor, Protocol Specific × Amifostine × Clear all
NCT00004919 2013-07-02

Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡